Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Tipo de estudo
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Int J Pharm ; 556: 311-319, 2019 Feb 10.
Artigo em Inglês | MEDLINE | ID: mdl-30557678

RESUMO

This study describes the preparation of free films of zein with and without acetylated high amylose maize starch (HAS) and their corresponding coated tablets as a novel approach to colonic drug delivery. We hypothesise that the embedding of a digestible starch component within the inert zein would allow the film to remain intact until the large intestine is reached. Free films of zein alone and starch/zein were prepared and characterized. SEM and AFM images of film surface showed that films were morphologically inhomogeneous, particularly at lower HAS/Zein ratios; however, nanothermal analysis data suggested that these differences in appearance within the same film are not compositional differences. Moreover, FT-IR could detect no molecular interaction between the two polymers. Paracetamol tablets were coated with HAS/Zein aqueous based coatings of different compositions to a TWG of 20%. Drug release from zein alone and 1:5 HAS/Zein coated tablets under upper gastrointestinal conditions (pH 1.2, pH 6.8 with pepsin and pancreatin included) was very similar (for example approximately 12% and 14% of the drug was released, respectively, after 6 h in a sequential in vitro test), suggesting that release in this region is limited and is not influenced by the presence of HAS in the ratio to zein under study. Studies using an in vitro colon model showed that under simulated colonic conditions, the drug release was significantly (p < 0.05) more rapid from 1:5 HAS/Zein, compared to the zein alone coating formulation. These data therefore support the potential use of zein-starch mixed films for colonic targeting purposes.


Assuntos
Amilose/química , Colo/metabolismo , Sistemas de Liberação de Medicamentos , Zeína/química , Acetaminofen/administração & dosagem , Acetaminofen/química , Acetilação , Administração Oral , Química Farmacêutica/métodos , Liberação Controlada de Fármacos , Humanos , Concentração de Íons de Hidrogênio , Polímeros , Espectroscopia de Infravermelho com Transformada de Fourier , Amido/química , Zea mays/química
2.
Planta ; 215(1): 79-89, 2002 May.
Artigo em Inglês | MEDLINE | ID: mdl-12012244

RESUMO

4-Hydroxycinnamoyl-CoA hydratase/lyase (HCHL), a crotonase homologue of phenylpropanoid catabolism from Pseudomonas fluorescens strain AN103, led to the formation of 4-hydroxybenzaldehyde metabolites when expressed in hairy root cultures of Datura stramonium L. established by transformation with Agrobacterium rhizogenes. The principal new compounds observed were the glucoside and glucose ester of 4-hydroxybenzoic acid, together with 4-hydroxybenzyl alcohol- O-beta- D-glucoside. In lines actively expressing HCHL, these together amounted to around 0.5% of tissue fresh mass. No protocatechuic derivatives were found, although a trace of vanillic acid-beta- D-glucoside was detected. There was no accumulation of 4-hydroxybenzaldehydes, whether free or in the form of their glucose conjugates. There was some evidence suggesting a diminished availability of feruloyl-CoA for the production of feruloyl putrescine and coniferyl alcohol. The findings are discussed in the context of a diversion of phenylpropanoid metabolism, and the ability of plants and plant cultures to conjugate phenolic compounds.


Assuntos
Datura stramonium/genética , Hidroliases/metabolismo , Raízes de Plantas/genética , Propanóis/metabolismo , Pseudomonas fluorescens/enzimologia , Benzaldeídos/metabolismo , Enoil-CoA Hidratase/metabolismo , Regulação Enzimológica da Expressão Gênica , Glucose/metabolismo , Hidroliases/genética , Lignina/metabolismo , Parabenos/metabolismo , Fenóis/metabolismo , Plantas Geneticamente Modificadas , Ácido Vanílico/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA